New generation drug eluting stent launched
Recently a new generation drug eluting stent — NoboriTM stent system of Terumo Corporation of Japan has been launched in the market of Bangladesh. A stent is a small, lattice-shaped, metal tube that is inserted permanently into an artery. The stent helps hold open an artery so that blood can flow through it. Drug-eluting stents are stents that contain drugs that potentially reduce the chance the arteries will become blocked again. Stents are widely used in interventional cardio- and cerebro-vascular diseases. NoboriTM stent system has a bioabsorbable polymer offering best in class clinical results and strong patient safety profile. NoboriTM stent system utilises biolimus A9TM, an analogue of Sirolimus, which is expected to reduce tissue proliferation. The stent delivery system applies Terumo's proprietary hydrophilic coating which enhances deliverability and reduces arterial wall damage. These were told at the launching ceremony at a local in the city, while National Prof Brig (Rtd) M A Malik was present as the Chairperson of the ceremony. Unimed Limited, Bangladesh will make the NoboriTM stent system available in the local market of Bangladesh.
For all latest news, follow The Daily Star's Google News channel.
Comments